TPEX:6712 Market Cap

TPEX:6712 has a market cap or net worth of 11.30 billion as of April 28, 2026. Its market cap has decreased by -18.51% in one year.

Market Cap

11.30B

Enterprise Value

10.90B

Revenue

1.02B

Ranking

n/a

PE Ratio

26.43

Stock Price

127.50

Market Cap Chart

Since October 26, 2018, TPEX:6712's market cap has increased from 5.10B to 11.30B, an increase of 121.74%. That is a compound annual growth rate of 11.19%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	11.30B	-21.34%
Dec 31, 2025	14.37B	1.47%
Dec 31, 2024	14.16B	-1.25%
Dec 29, 2023	14.34B	-4.57%
Dec 30, 2022	15.02B	15.46%
Dec 30, 2021	13.01B	32.03%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
CHO Pharma	11.39B
Tanvex BioPharma	10.62B
Locus Cell	13.12B
TaiMed Biologics	13.20B
EirGenix	13.95B
Gongwin Biopharm Holdings	8.73B
Polaris Group	15.05B
Medigen Vaccine Biologics	15.94B

Market Cap Rankings